Megan Boston

Megan Boston

Chief Financial Officer, SecretaryatBenitec Biopharma· In proxies 2022–2025

Pay in FY2025+498% from the year before · Benitec Biopharma stock +67.4% the same year

Megan Boston was paid $8.6M in FY2025 (Jun), up 498%. Benitec Biopharma stock rose 67.4% that year.

Pay$100 in the stock at the end of FY21 → $16
Pay is from the Summary Compensation Table of each Benitec Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Benitec BiopharmaPublic company · 4 yr
    • Chief Financial Officer, Secretary2022 – Present · 4 yrStock in role -88%

Roles come from the proxy statements of each company.

Boards1

  • Benitec BiopharmaDirector · 9 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?